Variant report
Variant | nsv977371 |
---|---|
Chromosome Location | chr13:67355754-67359844 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368315898 | chr13:67355808-67355809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535764844 | chr13:67355829-67355830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs144331738 | chr13:67355839-67355840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs572015832 | chr13:67355847-67355848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552768497 | chr13:67355854-67355855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557783481 | chr13:67355872-67355873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9540911 | chr13:67355886-67355887 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs543525884 | chr13:67355913-67355914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377242087 | chr13:67355918-67355919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563932927 | chr13:67355922-67355923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs148772307 | chr13:67355938-67355939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs376623076 | chr13:67355943-67355944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35254607 | chr13:67356018-67356019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs67858833 | chr13:67356019-67356020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs3042287 | chr13:67356021-67356022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs111878576 | chr13:67356022-67356023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs183704887 | chr13:67356058-67356059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559751359 | chr13:67356067-67356068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9540912 | chr13:67356095-67356096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34936581 | chr13:67356151-67356152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142431035 | chr13:67356158-67356159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551405633 | chr13:67356160-67356161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113523162 | chr13:67356162-67356163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530939942 | chr13:67356192-67356193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550770861 | chr13:67356193-67356194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139003814 | chr13:67356321-67356322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs535253969 | chr13:67356333-67356334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs74093604 | chr13:67356347-67356348 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs373785623 | chr13:67356368-67356369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs77856437 | chr13:67356483-67356484 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557818231 | chr13:67356511-67356512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569149773 | chr13:67356575-67356576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9564350 | chr13:67356584-67356585 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs556745238 | chr13:67356592-67356593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs377492158 | chr13:67356666-67356667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574182126 | chr13:67356675-67356676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554681579 | chr13:67356704-67356705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542902030 | chr13:67356729-67356730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs7994100 | chr13:67356731-67356732 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs534038255 | chr13:67356736-67356737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528797017 | chr13:67356737-67356738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9540913 | chr13:67356751-67356752 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs564960627 | chr13:67356752-67356753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539265491 | chr13:67356759-67356760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs111424752 | chr13:67356763-67356764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189312540 | chr13:67356782-67356783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs180987124 | chr13:67356809-67356810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530207408 | chr13:67356810-67356811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs542785062 | chr13:67356883-67356884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576929683 | chr13:67356927-67356928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Schizophrenia | 23813976 | CNVD |
Prostate cancer | 22341455 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:67346200-67368400 | Weak transcription | Brain Hippocampus Middle | brain |
2 | chr13:67354400-67355800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr13:67354600-67355800 | Enhancers | Muscle Satellite Cultured Cells | -- |
4 | chr13:67354800-67355800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr13:67355200-67356600 | Weak transcription | Fetal Brain Female | brain |
6 | chr13:67355400-67355800 | Enhancers | HSMMtube | muscle |
7 | chr13:67355600-67374000 | Weak transcription | HSMM | muscle |
8 | chr13:67355800-67357000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
9 | chr13:67356800-67357000 | Enhancers | Fetal Brain Female | brain |
10 | chr13:67357200-67357400 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr13:67357200-67357600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |